Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Understanding what depression is – and what it is not – is often the first step toward relief.
In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 of treatment, with durable pain reduction and significant improvements in all key secondary ...
Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults with chronic migraine.
I'm a 68-year-old man and I'm suffering with hot flushes. Sometimes I get as many as 15 a day, often during the night. What ...
Neuropathic pain is a devastating type of pain that significantly reduces the quality of life of affected people.
Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Late last year, I nearly passed out in my girlfriend’s bed. I had forgotten to breathe for what felt like a couple of minutes until, finally, I gasped, gulping hot air. My balls ached. My temples ...
Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, ...
TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results